MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Profit After Tax History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Profit After Tax | ₹1,941 Cr | ₹130,968 Cr | ₹1,453 Cr | ₹129 Cr | ₹10,561 Cr |
What is the latest Profit After Tax of MANKIND PHARMA ?
Year | Profit After Tax |
---|---|
Mar2025 | ₹1,941 Cr |
Mar2024 | ₹130,968 Cr |
Mar2023 | ₹1,453 Cr |
Mar2022 | ₹129 Cr |
Mar2021 | ₹10,561 Cr |
How is Profit After Tax of MANKIND PHARMA Trending?
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹1,941 Cr | -98.52 | |
Mar2024 | ₹130,968 Cr | 8,913.86 | |
Mar2023 | ₹1,453 Cr | 1,023.68 | |
Mar2022 | ₹129 Cr | -98.78 | |
Mar2021 | ₹10,561 Cr | - |
Compare Profit After Tax of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹103,203.9 Cr | -0.2% | -3.9% | 8.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹384,002.0 Cr | -2.1% | -5.8% | -6.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,334.0 Cr | 3.1% | -6.5% | 28.7% | Stock Analytics | |
CIPLA | ₹127,613.0 Cr | 2.2% | 3.2% | 1.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,923.0 Cr | -1.7% | NA | 9.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,437.0 Cr | 1.4% | -1.1% | -7.6% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | -0.2% |
-3.9% |
8.3% |
SENSEX | -1.1% |
-1.7% |
-0.3% |
You may also like the below Video Courses